These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 2848441)

  • 41. A rapid method for detecting Junin virus viremia in the guinea pig.
    Rabinovich A; Cossio PM; Carballal G; Arana RM
    Intervirology; 1977; 8(6):360-3. PubMed ID: 197047
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differentiation of Junin virus and antigenic variants isolated in vivo by kinetic neutralization assays.
    Alché LE; Coto CE
    J Gen Virol; 1988 Aug; 69 ( Pt 8)():2123-7. PubMed ID: 2841418
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Epidemiology of Argentine hemorrhagic fever.
    Carballal G; Videla CM; Merani MS
    Eur J Epidemiol; 1988 Jun; 4(2):259-74. PubMed ID: 2841151
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of immunosuppression on experimental Argentine hemorrhagic fever in guinea pigs.
    Kenyon RH; Green DE; Peters CJ
    J Virol; 1985 Jan; 53(1):75-80. PubMed ID: 2981364
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cross-protection in nonhuman primates against Argentine hemorrhagic fever.
    Weissenbacher MC; Coto CE; Calello MA; Rondinone SN; Damonte EB; Frigerio MJ
    Infect Immun; 1982 Feb; 35(2):425-30. PubMed ID: 6276301
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intracerebral infection of Cebus apella with the XJ-Clone 3 strain of Junín virus.
    Carballal G; Oubiña JR; Molinas FC; Nagle C; de la Vega MT; Videla C; Elsner B
    J Med Virol; 1987 Mar; 21(3):257-68. PubMed ID: 3031201
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Interferon in experimental infection with Junin virus].
    Teyssié AR; Knecher LM; Ayerra de Holstein BL
    Medicina (B Aires); 1981; 41(5):573-8. PubMed ID: 6178929
    [No Abstract]   [Full Text] [Related]  

  • 48. Immunofluorescent anti-Junin virus antibodies in Argentine hemorrhagic fever.
    Cossio PM; Rabinovich A; Maiztegui JI; Carballal G; Casanova MB; Ritacco V; Arana RM
    Intervirology; 1979; 12(1):26-31. PubMed ID: 227813
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long-term protection against Argentine hemorrhagic fever in Tacaribe virus infected marmosets: virologic and histopathologic findings.
    Samoilovich SR; Calello MA; Laguens RP; Weissenbacher MC
    J Med Virol; 1988 Feb; 24(2):229-36. PubMed ID: 2832541
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ribavirin therapy for lassa fever.
    Snell N
    Practitioner; 1988 Apr; 232(1447):432. PubMed ID: 3249720
    [No Abstract]   [Full Text] [Related]  

  • 51. Immune response to vaccination against Argentine hemorrhagic Fever in an area where different arenaviruses coexist.
    Ambrosio AM; Riera LM; Saavedra Mdel C; Sabattini MS
    Viral Immunol; 2006; 19(2):196-201. PubMed ID: 16817762
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prospects for the control of Bolivian hemorrhagic fever.
    Kilgore PE; Peters CJ; Mills JN; Rollin PE; Armstrong L; Khan AS; Ksiazek TG
    Emerg Infect Dis; 1995; 1(3):97-100. PubMed ID: 8903174
    [No Abstract]   [Full Text] [Related]  

  • 53. Lassa virus infection of rhesus monkeys: pathogenesis and treatment with ribavirin.
    Jahrling PB; Hesse RA; Eddy GA; Johnson KM; Callis RT; Stephen EL
    J Infect Dis; 1980 May; 141(5):580-9. PubMed ID: 6768812
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Study of sensitivity of laboratory animals to a causative agent of argentine hemorrhagic fever].
    Syromiatnikova SI; Pantiukhov VB; Shatokhina IV; Timofeev MA; Sizikova TE; Borisevich SV
    Zh Mikrobiol Epidemiol Immunobiol; 2014; (4):53-7. PubMed ID: 25286529
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Machupo Virus Expressing GPC of the Candid#1 Vaccine Strain of Junin Virus Is Highly Attenuated and Immunogenic.
    Koma T; Patterson M; Huang C; Seregin AV; Maharaj PD; Miller M; Smith JN; Walker AG; Hallam S; Paessler S
    J Virol; 2016 Feb; 90(3):1290-7. PubMed ID: 26581982
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ultrastructural and immunohistochemical studies in five cases of Argentine hemorrhagic fever.
    Maiztegui JI; Laguens RP; Cossio PM; Casanova MB; de la Vega MT; Ritacco V; Segal A; Fernández NJ; Arana RM
    J Infect Dis; 1975 Jul; 132(1):35-53. PubMed ID: 50390
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Protective efficacy of a live attenuated vaccine against Argentine hemorrhagic fever. AHF Study Group.
    Maiztegui JI; McKee KT; Barrera Oro JG; Harrison LH; Gibbs PH; Feuillade MR; Enria DA; Briggiler AM; Levis SC; Ambrosio AM; Halsey NA; Peters CJ
    J Infect Dis; 1998 Feb; 177(2):277-83. PubMed ID: 9466512
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Protection of Junín virus-infected marmosets by passive administration of immune serum: association with late neurologic signs.
    Avila MM; Samoilovich SR; Laguens RP; Merani MS; Weissenbacher MC
    J Med Virol; 1987 Jan; 21(1):67-74. PubMed ID: 3025358
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The study of protective properties of attenuated strain of Argentinian hemorrhagic fever].
    Ignat'ev GM; Blinov VM; Romanowski V
    Vopr Virusol; 1996; 41(4):158-61. PubMed ID: 8999669
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vitro selection of Junin virus antigenic variants.
    Alché LE; Coto CE
    Arch Virol; 1993; 128(3-4):389-94. PubMed ID: 8382041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.